Tygacil and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tygacil and Cymbalta. Common interactions include vomiting among females and blood alkaline phosphatase increased among males.

The phase IV clinical study analyzes what interactions people who take Tygacil and Cymbalta have. It is created by eHealthMe based on reports of 13 people who take Tygacil and Cymbalta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

13 people who take Tygacil and Cymbalta together, and have interactions are studied.

What is Tygacil?

Tygacil has active ingredients of tigecycline. eHealthMe is studying from 1,956 Tygacil users for its effectiveness, alternative drugs and more.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 145,318 Cymbalta users for its effectiveness, alternative drugs and more.

Number of Tygacil and Cymbalta reports submitted per year:

Common Tygacil and Cymbalta drug interactions by gender *:

female:

Vomiting
Gastrointestinal haemorrhage
Nausea
Cardio-respiratory arrest
Coagulopathy
Gastrointestinal stoma complication
Hypotension
Kidney infection
Multi-organ failure
Peritoneal disorder

male:

Blood alkaline phosphatase increased
Gamma-glutamyltransferase increased
Convulsion
Culture urine positive
Deep vein thrombosis
Dementia
Enterococcus test positive
Escherichia test positive
General physical health deterioration
Hypertension

Common Tygacil and Cymbalta drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Vomiting
Nausea

40-49:

Cardio-respiratory arrest
Gastrointestinal stoma complication
Hypotension
Multi-organ failure
Peritoneal disorder
Peritonitis
Pyrexia
Sepsis

50-59:

Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Gamma-glutamyltransferase increased
Cellulitis
Oedema

60+:

Gastrointestinal haemorrhage
Blood alkaline phosphatase increased
Culture urine positive
Deep vein thrombosis
Dementia
Enterococcus test positive
Escherichia test positive
General physical health deterioration
Hypertension
Hyponatraemia

Common conditions people have *:

Pain: 2 people, 15.38%
Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 2 people, 15.38%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.69%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Osteomyelitis Chronic (long lasting infection of bone marrow): 1 person, 7.69%
Infection: 1 person, 7.69%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tygacil and Cymbalta?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.